Privigen 10% vial 100ML
Ended Awarded Last action
- Contract number
- SPE2DR26FDJQ8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,359
Award facts
- Contract value 100% obligated
- $26,358.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $26,358.80 to DMS Pharmaceutical Group Inc. for PRIVIGEN 10% Vial 100ML, an intravenous immunoglobulin product, with an ultimate completion date of February 20, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating competitive capability in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling value and extends through December 31, 2036.
The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to support recurring pharmaceutical and medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has demonstrated substantial federal contracting activity as a critical supplier within the military medical supply chain, with a product portfolio encompassing branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The company's appointment as a regional prime vendor contractor under this major acquisition vehicle positions it to fulfill diverse and specialized pharmaceutical requirements for military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FDJQ8?
SPE2DR26FDJQ8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FDJQ8 worth?
The government has obligated $26,359 on SPE2DR26FDJQ8.
Is contract SPE2DR26FDJQ8 an order under another contract?
Yes. SPE2DR26FDJQ8 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDJQ8 competed?
The extent of competition for SPE2DR26FDJQ8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award